Global Allergy Diagnostics Market

Allergy Diagnostics Market Size, Share, Growth Analysis, By Product (Consumables, Instruments (Immunoassay Analyzers, ELISA Analyzers, Luminometers, Other Instruments), Services), By Allergens (Inhaled Allergens, Food Allergens, Drug Allergens, Other Allergens), By Test Type (Vivo Tests, In Vitro Tests), By Region - Industry Forecast 2024-2031


Report ID: SQSG35I2040 | Region: Global | Published Date: September, 2024
Pages: 165 | Tables: 123 | Figures: 73

Allergy Diagnostics Market Insights

Allergy Diagnostics Market size was valued at around USD 4.3 billion in 2022 and is expected to rise from USD 4.8 billion in 2023 to reach a value of USD 11.1 billion by 2031, at a CAGR of 11% over the forecast period (2024–2031).

As pollution levels rise, the market for allergy diagnostics is projected to expand. The main risk factors for chronic respiratory illnesses include allergen exposure, occupational exposure, and exposure to indoor and outdoor air pollution. Because of their higher exposure to pollution, city dwellers are more prone than rural dwellers to suffer allergy disorders. The rise in food allergies is expected to boost the growth of the allergy diagnostic market.

Food allergy is a form of allergic sickness that is more common in cities and first-world countries than in rural and third-world countries. The degree of cleanliness and the risk of infectious diseases are two of the most noticeable differences between these regions. Early exposure to bacterial, viral, and parasitic infections, as well as exposure to a variety of common human body microbes, are likely to influence immune system development. Climate change, air pollution, and the complexity of materials and cosmetic products have all contributed to a rise in the prevalence of sensitive skin and its proclivity for irritation. These factors are expected to drive the growth of the allergy diagnostics market in the near future.

US Allergy Diagnostics Market  is poised to grow at a sustainable CAGR for the next forecast year.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Allergy Diagnostics Market size was valued at around USD 4.3 billion in 2022 and is expected to rise from USD 4.8 billion in 2023 to reach a value of USD 11.1 billion by 2031, at a CAGR of 11% over the forecast period (2024–2031).

The global allergy diagnostics market is highly competitive and companies are actively involved in new product launches, strategic collaborations, acquisitions, and technological advancements to gain maximum market share. 'Danaher Corporation ', 'Thermo Fisher Scientific Inc. ', 'Canon, Inc. (Minaris Medical America, Inc.) ', 'Siemens Healthineers AG ', 'Eurofins Scientific ', 'Revvity, Inc. (Euroimmun Medizinische Labor diagnostika AG) ', 'BioMérieux SA ', 'Stallergenes Greer Ltd. ', 'Romer Labs Division Holding GmbH ', 'HollisterStier Allergy ', 'Omega Diagnostics Group PLC ', 'HOB Biotech Group Corp., Ltd. ', 'Hycor Biomedical ', 'Lincoln Diagnostics, Inc. ', 'R-Biopharm AG ', 'Astra Biotech GmbH ', 'Erba Group ', 'AESKU.GROUP GmbH ', 'ACON Laboratories, Inc. ', 'Alcit India Pvt. Ltd. ', 'Biopanda Reagents Ltd. ', 'Bioside S.R.L. ', 'Creative Diagnostic Medicare Pvt. Ltd. ', 'DST Diagnostische Systeme & Technologien GmbH ', 'Dr. Fooke Laboratorien GmbH'

The main risk factors for chronic respiratory disorders are exposure to indoor and outdoor air pollution, allergies, and occupational exposure. Because of the higher exposure to environmental pollutants in cities, the prevalence of allergy disorders among the urban population is higher than among the rural population (as a result of vehicular pollution and industrial activities). According to the WHO, more than 80% of people living in urban areas are exposed to air quality levels that exceed WHO safety guidelines; while this is a global trend, the consequences are particularly severe in low-income countries' urban regions. This is a significant indicator for the growth of the allergy diagnostics market, as air pollution from motor vehicles has been identified as a key risk factor for allergic illnesses.

Reagent rental agreements are gaining traction to reduce the high costs of allergy diagnostics. Reagent rental agreements are sales contracts between allergy diagnostic product manufacturers and end users (such as hospitals and diagnostic laboratories). The end user leases or purchases instruments at a subsidized rate under these agreements by engaging into a reagent-purchase contract with the manufacturer. This mutually advantageous agreement reduces the end user's initial capital commitment while assuring the manufacturer of long-term orders. In some circumstances, analyzers are rented to end users on a per-test basis. Reagent rental agreements and cost-per-test contracts provide considerable cost-cutting advantages to laboratories. They also assist laboratories in avoiding large fixed capital expenses connected with the acquisition of new equipment. These costs are significantly greater in high-volume laboratories than in regular laboratories. Furthermore, with the average contract lasting between 5 and 10 years, laboratories may stay up to speed on the newest advancements in allergy diagnostics. Some contracts incorporate service/maintenance costs in the entire cost, providing laboratories with extra savings.

In terms of revenue, North America led the global market in 2021 due to a high frequency of respiratory allergic illnesses, increased awareness of allergy diagnostics, and the use of in vitro blood testing. Due to the presence of a strong pharmaceutical sector and rising demand for treatments, Europe is likely to be the second-largest regional market. The region's expansion is also being fueled by an aging population and an increase in allergy disorders. Due to rapidly improving healthcare infrastructure, unmet clinical needs, and demand for minimally invasive diagnostic instruments, Asia Pacific is predicted to be the fastest-growing regional market, with a CAGR of 13.2% over the forecast period.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Allergy Diagnostics Market

Report ID: SQSG35I2040

$5,300
BUY NOW GET FREE SAMPLE